Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
126.03
-1.64 (-1.28%)
Nov 13, 2024, 4:00 PM EST - Market closed
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $7.53 billion as of November 13, 2024. Its market cap has increased by 53.28% in one year.
Market Cap
7.53B
Enterprise Value
8.07B
1-Year Change
53.28%
Ranking
Category
Stock Price
$126.03
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $7.53B, an increase of 1,578.17%. That is a compound annual growth rate of 33.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 7.32B | 0.82% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.76B |
| Madrigal Pharmaceuticals | 7.65B |
| Viking Therapeutics | 7.63B |
| Grifols | 7.52B |
| Jazz Pharmaceuticals | 7.47B |
| Legend Biotech | 7.38B |
| Bausch + Lomb | 7.04B |
| Elanco Animal Health | 6.96B |